Li‐Tzong Chen
0000-0003-3250-7167
Publication & Citation Trends
Publications
0 total
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study
Cited by 2
Semantic Scholar
Carbohydrate Antigen 19-9 Response to Initial Adjuvant Chemotherapy Predicts Survival and Failure Pattern of Resected Pancreatic Adenocarcinoma but Not Which Patients Are Suited for Additional Adjuvant Chemoradiation Therapy: From a Prospective Randomized Study.
Cited by 4
Semantic Scholar
The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study OA
Cited by 5
Semantic Scholar
Small pancreas neuroendocrine tumors: How small is small? OA
Cited by 0
Semantic Scholar
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer OA
Cited by 6
Semantic Scholar
ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer.
Cited by 36
Semantic Scholar
A phase Ib/II study of GFH018 in combination with toripalimab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC).
Cited by 3
Semantic Scholar
Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors
Cited by 8
Semantic Scholar
Research Topics
Pancreatic and Hepatic Oncology Research
(133)
Cholangiocarcinoma and Gallbladder Cancer Studies
(90)
Gastric Cancer Management and Outcomes
(79)
Sarcoma Diagnosis and Treatment
(49)
Neuroendocrine Tumor Research Advances
(45)
Affiliations
Tainan University of Technology
National Taipei University of Technology
Chung Hwa University of Medical Technology
Tri-Service General Hospital
Apple (Israel)